FDA reports over 100 drug shortages nationwide
NASHVILLE, Tennessee (WKRN) – Recent supply chain disruptions are impacting everything from clothes to food, and even trips to the drugstore. Popular drugs like Adderall, Oxycodone, and Insulin are weak across the country.
In Tennessee, Steve Beasley said he’s struggling to find iron dextran for his iron infusions. “I’m stuck between a rock and a hard place right now – none of the pharmacies here can get it where they can prepare it in-house.”
The FDA currently lists 112 drug shortages on its website. The reasons for the arrears all vary.
âSome companies have stopped manufacturing [iron dextran] for some reason, âBeasley said. “I don’t know, it just says manufacturing delays.”
Life-saving drug Narcan is also affected, with Pfizer’s website reporting that the availability of its injectable naloxone formulation has run out. âA big reason there is a shortage – Pfizer had a manufacturing problem around the start of the year,â said Tara Schiller, CEO of SoberBuddy.
One of the groups affected by the shortage is the Opioid Safety and Supply Network (OSSN) Buyers Club. The group is the largest source of naloxone distribution directly to affected communities, accounting for 1.3 million doses in 2020 alone.
The OSNN Buyers Club said it has an exclusive agreement with Pfizer for the low-cost generic injectable. While there is no generalized shortage of the product itself, the shortage specifically affects the program group. As of August 2021, the OSNN Buyers Club programs were out of stock by more than a quarter of a million doses of naloxone.
This shortage problem creates a “perfect storm” scenario where overdoses skyrocket, but access to life-saving drugs collapses, Schiller said. “This group distributes in areas where there is no government infrastructure to purchase naloxone.”
Nexstar contacted the FDA regarding the shortages and received the following response:
âThe FDA actively monitors drug availability and we are committed to working with our public health partners, manufacturers and distributors to help alleviate shortages and ensure patients’ continued access to life-saving, safe and effective drugs. . “
Suggest a correction